HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels
Author(s) -
V.C. Di Maio,
Valeria Cento,
D. Di Paolo,
M. Aragri,
F. De Leonardis,
Monica Tontodonati,
Valeria Micheli,
Maria Concetta Bellocchi,
F.P. Antonucci,
Ada Bertoli,
I. Lenci,
Martina Milana,
Laura Gianserra,
M. Melis,
Antonio Di Biagio,
C. Sarrecchia,
Loredana Sarmati,
Simona Landonio,
S. Francioso,
L. Lambiase,
Laura Ambra Nicolini,
Stefano Marenco,
L. Nosotti,
Valerio Giannelli,
Massimo Siciliano,
Dante Romagnoli,
Adriano Pellicelli,
Jacopo Vecchiet,
C. Magni,
Sergio Babudieri,
M.S. Mura,
Gloria Taliani,
Claudio Maria Mastroianni,
Umberto VespasianiGentilucci,
Marco Romano,
Filomena Morisco,
Antonio Gasbarrini,
Vincenzo Vullo,
Savino Bruno,
Chiara Baiguera,
C. Pasquazzi,
Giuseppe Tisone,
A. Picciotto,
Massimo Andreoni,
Giustino Parruti,
Giuliano Rizzardini,
M. Angélico,
Carlo Federico Perno,
Francesca CeccheriniSilberstein
Publication year - 2015
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkv403
Subject(s) - genotype , telaprevir , virology , genotyping , hepatitis c virus , concordance , boceprevir , ns5b , simeprevir , biology , ns3 , hepacivirus , sanger sequencing , medicine , dna sequencing , virus , genetics , gene , ribavirin
This study aims to evaluate the reliability and clinical utility of NS3 sequencing in hepatitis C virus (HCV) 1-infected patients who were candidates to start a PI-containing regimen.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom